Project Grant R01HL182806
- Federal Grant Award Summary Award Details: Emory University received a Project Grant of $162,080 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The award was issued on March 13, 2026, with an ultimate completion date of September 11, 2027, and will be performed at Emory's Atlanta, Georgia campus. Research Scope: The project, titled "Defining the Function of C/EBP-Beta and Its Downstream Target PSMB9 in...
- Federal Grant Award Summary Emory University's Office of Sponsored Programs received a $156,080 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective March 13, 2026, with completion targeted for September 11, 2027. The research project, "HEG1 as a Regulator of Hypertension and Atherosclerosis," investigates the molecular and physiological mechanisms linking the flow-sensitive gene Heart...
- Federal Grant Award Summary Emory University's Office of Sponsored Programs received a $232,498 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded August 15, 2025, with a completion date of July 31, 2027. The grant supports the development of a predictive risk model for Fontan failure—a serious complication affecting pediatric and adult patients with rare single ventricle heart defects who have...
- Federal Project Grant Award Summary Emory University received a $391,211 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective June 1, 2026, through May 31, 2029. The award funds research investigating alloimmune responses to hemophilia therapeutics, specifically examining the mechanisms underlying anti-drug antibody development against coagulation factor proteins. The research addresses a critical...
- Federal Project Grant Award Summary Emory University received a $1.418M Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 1, 2025, with completion targeted for June 30, 2029. The award funds research to investigate the role of protein phosphatase 2A (PP2A) in takotsubo syndrome (TTS), also known as stress-induced cardiomyopathy or broken heart syndrome—a condition characterized by sudden,...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Emory University $110,635 under the Cardiovascular Diseases Research program (CFDA 93.837) on September 12, 2025, for a project grant extending through August 31, 2027. The award funds research investigating the role of blood rheology and transfusion interventions in microvascular thrombosis during sepsis. The project will utilize microfluidics assays to characterize how red blood cell (RBC) aggregation and...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a Project Grant totaling $811,885 to the J. David Gladstone Institutes under the Cardiovascular Diseases Research program (CFDA 93.837) on September 12, 2025. The award funds research to elucidate epigenomic mechanisms of cardiac fibrosis and heart failure pathogenesis, with a completion date of May 31, 2029. The research leverages novel genetic mouse models, advanced transcriptional and epigenomic...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Emory University a $234,750 project grant effective August 1, 2025, through July 31, 2027, under the Cardiovascular Diseases Research program (CFDA 93.837). This grant supports basic immunological research investigating anti-Factor VIII (FVIII) Immunoglobulin M (IgM) responses in hemophilia A patients. The research aims to identify immunologic mechanisms that initiate and orchestrate the formation...
- Federal Project Grant Summary Trustees of Dartmouth College, through its Office of Sponsored Projects, received a $157,040 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 30, 2025, with completion targeted for September 29, 2028. The award funds basic research investigating the hematopoietic origins and functional heterogeneity of macrophages—versatile innate immune cells critical...
- Federal Project Grant Award Summary Baylor College of Medicine received a $1.28 million Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded August 1, 2025, and scheduled for completion May 31, 2030. The award funds mechanistic research investigating how cardiac tissue-resident macrophages (TRMs) contribute to adverse cardiac remodeling in heart failure conditions. The research deliverables include...
Emory University received a $498,155 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective July 1, 2026 through March 31, 2030. The award funds basic research investigating the mechanisms controlling macrophage response during heart regeneration in zebrafish models. The project addresses fundamental questions about how the inflammatory-to-regenerative transition occurs following cardiac injury, with particular focus on macrophage phenotypic heterogeneity, epicardial cell activation, and molecular signaling pathways that facilitate cardiomyocyte proliferation and tissue repair. The research deliverables include mechanistic characterization of dynamic macrophage populations using single-cell RNA sequencing (scRNA-seq) and transgenic reporter analyses to understand how early injury-associated macrophages are cleared while reparative macrophages are recruited and retained. By elucidating these regeneration mechanisms in the zebrafish model system, the project aims to generate foundational knowledge that can inform therapeutic strategies to promote cardiac regeneration and prevent heart failure in mammals—the leading cause of morbidity and mortality in the United States. Research will be conducted at Emory University's Atlanta, Georgia campus.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $498.2k | 6/30/26 |